TrialThe journal of headache and pain2022

Real-world effectiveness after initiating fremanezumab treatment in US patients with episodic and chronic migraine or difficult-to-treat migraine.

Maurice T Driessen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.